This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.  View our privacy policy to learn more.
OK
AnnouncementsBlogsCommunitiesDiscussionsEventsGlossarySite ContentLibraries
on this day
between these dates
Posted by
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
The Connect Community Create AccountMy ProfileMy CommunitiesMy LibrariesMember DirectoryOpen ForumAbout SITC CONNECTThe Sentinel - SITC BlogEducation & Scientific Exchange SITC connectEDAnnual Meeting & Pre-Conference Programs ArchiveSITC17 Webcast Continuing EducationAdvances in Cancer Immunotherapy™ Online 2016 Advances in Cancer Immunotherapy™ Program ArchiveAdvances in Cancer Immunotherapy™ Online 2016 Advances in Cancer Immunotherapy™ Program ArchiveCME/CERegistrationWebcast RegistrationEnduring Materials 20162018 Charleston, SC - 2.24CME/CERegistrationWebcast RegistrationEnduring Materials 20162018-2019 Madison, Wis. - 9/6 WebcastMadison, Wis. - 9/6Boston, Mass. - 9/27Indianapolis, Ind. - 10/25Minneapolis, Minn. - TBDSeattle, Wash. - 11/3New York City, N.Y. - 11/15Louisville, Ky. - 12/6Pittsburgh, Penn. - 12/15Sacramento, Calif. - 1/10New Orleans, La. - 4/6/19Houston, Texas - 2/9Portland, Ore - 2/21Denver, Co. - TBDSalt Lake City, Utah - TBDToronto, Ont. - TBDACI Planning CommitteeProgram PurposeSITC Collaborative Education Programs ArchiveCancer Immunotherapy Winter School RegistrationSITC Sparkathon Application DetailsMatching Donation ChallengeBusiness CoachesSITC Sparkathon Class of 2017 Projects Team TimIOsThe METIOR Incubator ApplicationThe METIOR Incubator: Checkpoints TeamThe METIOR Incubator: CAR T Cell TeamThe METIOR Incubator MentorsSITC Sparkathon Class of 2018 Projects Team TimIOsThe METIOR Incubator ApplicationThe METIOR Incubator: Checkpoints TeamThe METIOR Incubator: CAR T Cell TeamThe METIOR Incubator MentorsThe METIOR Incubator: CAR T Cell Team2017 Cohort redirectMobile AppsMeet-the-Expert WebinarsUpcoming Events SITC Meeting Code of ConductResearch Journal for ImmunoTherapy of Cancer Submit a ManuscriptJITC Editorial BoardMonthly JITC Digest 2018 JITC Digest January 2018JITC Digest February 2018JITC Digest March 2018JITC Digest April 2018JITC Digest May 2018JITC Digest June 2018JITC Digest July 2018JITC Digest August 2018JITC Digest September 2018JITC Digest October 2018JITC Digest November 2018JITC Digest December 20182016 JITC Digest December 20162017 JITC Digest August 2017JITC Digest September 2017JITC Digest October 2017JITC Digest July 2017JITC Digest June 2017JITC Digest May 2017JITC Digest April 2017JITC Digest March 2017JITC Digest February 2017JITC Digest January 20172019 JITC Digest January 2019Frequently Asked Questions - Impact Factors and IndexingEditors' Picks Top Articles of 2017SITC Cancer Immunotherapy Guidelines Cutaneous Melanoma Cutaneous Melanoma - Current AlgorithmsGenitourinary Malignancies BladderKidneyProstateHematologic MalignanciesLung CancerOpen Comment PeriodsAcute LeukemiaHead and NeckCIG Webinar: DisclosuresCIG Melanoma Webinar: Continuing Education CreditsCIG Lung Webinar: Continuing Education CreditsCancer Immunotherapy Guideline Webinars: On-DemandMultiple MyelomaLymphomaImmune-related Adverse EventsImmune BiomarkersImmunoscore ValidationCombination ImmunotherapiesImmune ResponsivenessCancer Immunotherapy Principles and Practice TextbookAdvocacy & Policy Advocacy, Education & Lobbying Archive 201520162017Regulatory IssuesStandards & Quality of CareValue of ImmunotherapyMembership Join/Member BenefitsMembership CategoriesCorporate MembershipVolunteer Committees Cancer Immunotherapy Guidelines Myeloma SubcommitteeCancer Immunotherapy Guidelines Non-Small Cell Lung Cancer (NSCLC) SubcommitteeRegulatory SubcommitteeInternational CommitteeScience and Research SubcommitteeEarly Career ScientistCommunicationsIndustryExecutive CouncilAnnual ProgramChampionsImmune BiomarkersBiomarker Data Sharing SubcommitteeMicrobiome SubcommitteeResources & Useful Tools SubcommitteeTumor Mutational Burden SubcommitteeCancer Immunotherapy Guidelines Renal Cell Carcinoma SubcommitteeMembershipQuality SubcommitteeEducation and Training CommitteeAdvances in Cancer Immunotherapy™ (ACI) CommitteeForward Fund CommitteeCancer Immunotherapy Guidelines Acute Leukemia SubcommitteePolicy and Advocacy CommitteeBylawsAdvocacy SubcommitteeCancer Immunotherapy Guidelines CommitteeCombination Therapies CommitteePublicationsCancer Immunotherapy Guidelines Lymphoma SubcommitteeCancer Immunotherapy Guidelines Melanoma SubcommitteeFinance CommitteeCancer Immunotherapy Guidelines Bladder Carcinoma SubcommitteeNominating SubcommitteeCancer Immunotherapy Guidelines Immune-Related Adverse Event SubcommitteeInternational Young Investigator SubcommitteeCancer Immunotherapy Guidelines Prostate Carcinoma SubcommitteeAwards ReviewCancer Immunotherapy Guidelines Head and Neck SubcommitteeImmunoscore Steering CommitteeSITC Task Forces Cancer Immune Responsiveness Task ForceBiomarkers Biomarkers Task Force 2009-2012Biomarkers Task Force 2014 - presentImmune Monitoring Technology Primer SeriesPathology Task ForceGenitourinary Malignancies Task ForceImmunoscore Steering Key Information ReleaseSITC Volunteer Portal About SITC Volunteer PortalVolunteer OpportunitiesSITC Volunteer LeaderboardSITC Volunteer Groups World Immunotherapy Council (WIC)RenewVolunteer Committees Cancer Immunotherapy Guidelines Myeloma SubcommitteeCancer Immunotherapy Guidelines Non-Small Cell Lung Cancer (NSCLC) SubcommitteeRegulatory SubcommitteeInternational CommitteeScience and Research SubcommitteeEarly Career ScientistCommunicationsIndustryExecutive CouncilAnnual ProgramChampionsImmune BiomarkersBiomarker Data Sharing SubcommitteeMicrobiome SubcommitteeResources & Useful Tools SubcommitteeTumor Mutational Burden SubcommitteeCancer Immunotherapy Guidelines Renal Cell Carcinoma SubcommitteeMembershipQuality SubcommitteeEducation and Training CommitteeAdvances in Cancer Immunotherapy™ (ACI) CommitteeForward Fund CommitteeCancer Immunotherapy Guidelines Acute Leukemia SubcommitteePolicy and Advocacy CommitteeBylawsAdvocacy SubcommitteeCancer Immunotherapy Guidelines CommitteeCombination Therapies CommitteePublicationsCancer Immunotherapy Guidelines Lymphoma SubcommitteeCancer Immunotherapy Guidelines Melanoma SubcommitteeFinance CommitteeCancer Immunotherapy Guidelines Bladder Carcinoma SubcommitteeNominating SubcommitteeCancer Immunotherapy Guidelines Immune-Related Adverse Event SubcommitteeInternational Young Investigator SubcommitteeCancer Immunotherapy Guidelines Prostate Carcinoma SubcommitteeAwards ReviewCancer Immunotherapy Guidelines Head and Neck SubcommitteeImmunoscore Steering CommitteeSITC Task Forces Cancer Immune Responsiveness Task ForceCertification Task ForceBiomarkers Biomarkers Task Force 2009-2012Biomarkers Task Force 2014 - presentImmune Monitoring Technology Primer SeriesPathology Task ForceGenitourinary Malignancies Task ForceImmunoscore Steering Key Information ReleaseSITC Volunteer Groups World Immunotherapy Council (WIC)Connect-a-ColleagueFunding Support SITCFaces of the Forward Fund2018 SITC SupportersFellowships FAQAwards 201420152016201720182017 NCI Immunotherapy FellowshipGenentech-KohrtMerck2018 SITC-BMS Translational Fellowship AwardSITC-AstraZeneca ClinicalSITC-Merck Cancer Immunotherapy Clinical Fellowship AwardSITC-SU2C Convergence Scholar Awards SU2C-SITC Convergence Scholar Award 1SU2C-SITC Convergence Scholar Award 2SU2C-SITC Convergence Scholar Award 3SU2C-SITC Convergence Scholar Award 42019 SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship AwardSITC-AstraZeneca Immunotherapy in Lung Cancer (Early Stage NSCLC) Clinical Fellowship AwardSITCs Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship AwardNCI Immunotherapy FellowshipAwards Richard V. Smalley, MD, Memorial Award and Lectureship Richard V. Smalley Biography20052006200720082009201020112012201320142015201620172018JITC Best Paper Awards 20162015201420172018 YearPresidential AwardsYoung Investigator AwardsInternational ScholarsThe CheckPoints BandResearch Funding OpportunitiesAbout SITC Mission & VisionSupport SITC Corporate OpportunitiesPartnershipsHistory of SITC 1986 - 1991: Early Visions1992 - 1998: Finding Our Way1999 - 2006: Growth and Prosperity2007 - 2009: A New EraBoard of Directors SITC Board of DirectorsJob BoardCommittees, Task Forces and Professional Interest CommunitiesMedia Room Cancer Immunotherapy MonthMedia ResourcesImmunotherapy NewsMeeting Highlights 2017 ESMO 20172016201520142018 AACR 2018ASCO 2018 Meeting HighlightsASH 2018 Meeting HighlightsSITC StaffContact SITC
Education & Scientific ExchangeCancer Immunotherapy Winter School
Cancer Immunotherapy Winter School
Attend the Cancer Immunotherapy Winter SchoolNew Comprehensive Cancer Immunotherapy Program Provides Advanced Training
Join the Society for Immunotherapy of Cancer (SITC) for this comprehensive cancer immunotherapy program, in Mesa, Ariz., Feb. 18–22, 2019. Taught by leading experts, this five-day program will provide attendees a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examine developing areas in the field.
Tailored to early career scientists and clinicians in the field, the program will first cover the fundamentals of cancer immunotherapy before allowing participants to tailor their experience by selecting the track most relevant to their educational goals.
Over the course of the week, attendees will learn about:
Core principles of tumor immunology and cancer immunotherapy
Biomarker technology, validation and clinical integration
Clinical trial design, data analysis and considerations for combination therapies
Grant writing to obtain research funding
As attendees deepen their understanding, they will also benefit from professional development while interacting with faculty and thought leaders in this intimate setting.
Program ORGANIZERS
Lisa H. Butterfield, PhD – PICI Research Center, Parker Institute for Cancer Immunotherapy; University of California, San FranciscoLeisha A. Emens, MD, PhD – UPMC Hillman Cancer CenterMichael A. Morse, MD – Duke University Medical Center
Who should attend?
Graduate students, postdoctoral fellows and clinical fellows in the field of cancer immunotherapy
Individuals new to the field working in academic, clinical, industry and government settings
If you would like to attend this program, consider connecting with your supervisor. Here is a brief email (linked here) that you may use to help gain your supervisor’s support of your attendance to this one-of-a-kind program.Program SchedulesPlease click on the buttons below to view the program schedules for each track.
Clinical Track
RESEARCH TRACKFeb. 18–22, 2019Register Now
Register online by Feb. 11, 2019, at 5 p.m. EST.
Registration RatesDelta Hotels Phoenix Mesa200 North Centennial WayMesa, Ariz. 85201Please make your hotel reservation using the “Reserve Your Hotel Room” button below.Receive the discounted rate of $169 per night (offered to registered attendees). Reserve your room by Jan. 25, 2019. RESERVE YOUR HOTEL ROOM
Membership Links
Join
Renew
Member Directory
My ProfileGet Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2019 Society for Immunotherapy of Cancer (SITC). All rights reserved. Privacy Policy.
555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: info@sitcancer.org
Powered by Higher Logic